People Briefs

Theodore Friedmann, professor of pediatrics at the University of California, San Diego School of Medicine, has been appointed to the Muriel Jeannette Whitehill Chair for Biomedical Ethics at the school. Friedmann, who has been at UC-San Diego since 1969, has focused his research efforts on the genetic mechanisms underlying disease and the development of methods to correct genetic defects. In a benchmark 1972 essay in Science (175:949-55), Friedmann introduced the phrase "gene therapy" to descr

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Theodore Friedmann, professor of pediatrics at the University of California, San Diego School of Medicine, has been appointed to the Muriel Jeannette Whitehill Chair for Biomedical Ethics at the school. Friedmann, who has been at UC-San Diego since 1969, has focused his research efforts on the genetic mechanisms underlying disease and the development of methods to correct genetic defects.

In a benchmark 1972 essay in Science (175:949-55), Friedmann introduced the phrase "gene therapy" to describe the potential of treating genetic diseases by replacing defective genes with normal ones. In the same essay, he also posed a series of ethical questions that today are used as discussion guidelines by those who conduct and monitor biomedical research.

As Whitehill professor, Friedmann will continue his collaboration with other UC-San Diego faculty who are applying genetics to the understanding and, potentially, the treatment of heart disease, cancer, and neurological disorders such as Parkinson's disease. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies